Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Deferred Taxes (2016 - 2017)

Wave Life Sciences' Deferred Taxes history spans 3 years, with the latest figure at $4000.0 for Q4 2017.

  • For Q4 2017, Deferred Taxes rose 100.46% year-over-year to $4000.0; the TTM value through Dec 2017 reached $908000.0, up 230.09%, while the annual FY2017 figure was $908000.0, 230.09% up from the prior year.
  • Deferred Taxes reached $4000.0 in Q4 2017 per WVE's latest filing, down from $772000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $772000.0 in Q3 2017 to a low of -$876000.0 in Q4 2016.
  • Average Deferred Taxes over 3 years is $20500.0, with a median of $48500.0 recorded in 2015.
  • The largest YoY upside for Deferred Taxes was 577.08% in 2017 against a maximum downside of 3760.0% in 2017.
  • A 3-year view of Deferred Taxes shows it stood at -$146000.0 in 2015, then crashed by 500.0% to -$876000.0 in 2016, then soared by 100.46% to $4000.0 in 2017.
  • Per Business Quant, the three most recent readings for WVE's Deferred Taxes are $4000.0 (Q4 2017), $772000.0 (Q3 2017), and $325000.0 (Q2 2017).